e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about autoimmune diseases
Recent news which mentions autoimmune diseases
Exploring Pathways in Immune-Mediated Diseases To Advance Patient Care
September 14, 2022
Tickers
BMY
Tags
Pathway Medicine
Bristol Myers Squibb
Autoimmune Diseases
From
3BL Media: Corporate Social Responsibility, Energy and Health News
InflaRx's Vilobelimab Shows Encouraging Action Against Rare Autoimmune Disorder
November 15, 2021
Tickers
IFRX
Tags
Benzinga
IFRX
autoimmune diseases
From
Benzinga
Selecta In-Licenses Rights To IgG Protease Platform
October 21, 2021
Tickers
SELB
Tags
Penny Stocks
Briefs
Health Care
From
Benzinga
Brickell Biotech Acquires Rights To Candidate For Autoimmune Diseases
September 01, 2021
Tickers
BBI
Tags
Penny Stocks
BBI
Briefs
From
Benzinga
Galmed's Anti-Inflammatory Compound Shows Encouraging Preclinical Action
August 19, 2021
Tickers
GLMD
Tags
GLMD
Biotech
Penny Stocks
From
Benzinga
Cabaletta Bio's Cell Therapy Shows Encouraging Safety Profile In Autoimmune Skin Disorder
August 18, 2021
Tickers
CABA
Tags
Briefs
Biotech
Health Care
From
Benzinga
Aurinia Adds Two Assets To Expand Its Immunology Pipeline
August 17, 2021
Tickers
AUPH
Tags
Briefs
Health Care
Benzinga
From
Benzinga
Equillium's Itolizumab Reduces Urine Protein In Lupus Patients
August 12, 2021
Tickers
EQ
Tags
EQ
Benzinga
General
From
Benzinga
Moderna Takes Its First Autoimmune Therapeutic Candidate To Human Trial
August 02, 2021
Tickers
MRNA
Tags
General
Benzinga
Market News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.